{"entity":{"type":"insider","cik":"0001379222","url":"/insider/0001379222","json_url":"/insider/0001379222.json","name":"Hutson Nancy J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":33,"n_filings":30,"first":"2007-03-13","last":"2024-12-16","span_basis":"filed_date"},"name_variants":[{"name":"Hutson Nancy J","source":"filing","n_filings":30,"first_seen":"2007-03-13","last_seen":"2024-12-16"}],"transactions":[{"id":2242249,"accession":"0001127602-24-029494","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-029494","line_url":"/filing/0001127602-24-029494#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":7.54,"price_display":"7.54","price_state":"stated","total_value":52780.0,"total_display":"52,780.00","total_whole":"52,780","shares_owned_after":86638.0,"shares_owned_after_display":"86,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-13","filed_date":"2024-12-16","scope":"insider"},{"id":2053330,"accession":"0001127602-24-016190","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-016190","line_url":"/filing/0001127602-24-016190#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":6.38,"price_display":"6.38","price_state":"stated","total_value":31900.0,"total_display":"31,900.00","total_whole":"31,900","shares_owned_after":86818.0,"shares_owned_after_display":"86,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-20","filed_date":"2024-05-22","scope":"insider"},{"id":8501962,"accession":"0001209191-23-052027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-052027","line_url":"/filing/0001209191-23-052027#line-1","is_derivative":false,"issuer_cik":"0001379222","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001379222","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.86,"price_display":"0.86","price_state":"stated","total_value":8600.0,"total_display":"8,600.00","total_whole":"8,600","shares_owned_after":93000.0,"shares_owned_after_display":"93,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-03","filed_date":"2023-10-04","scope":"insider"},{"id":8432353,"accession":"0001127602-23-018775","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-018775","line_url":"/filing/0001127602-23-018775#line-2","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12866.0,"shares_display":"12,866","price_per_share":8.04,"price_display":"8.04","price_state":"stated","total_value":103442.64,"total_display":"103,442.64","total_whole":"103,443","shares_owned_after":81818.0,"shares_owned_after_display":"81,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-14","filed_date":"2023-06-15","scope":"insider"},{"id":6788347,"accession":"0001209191-22-058025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-058025","line_url":"/filing/0001209191-22-058025#line-1","is_derivative":false,"issuer_cik":"0001379222","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001379222","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":1.33,"price_display":"1.33","price_state":"stated","total_value":39900.0,"total_display":"39,900.00","total_whole":"39,900","shares_owned_after":83000.0,"shares_owned_after_display":"83,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-17","filed_date":"2022-11-21","scope":"insider"},{"id":5214469,"accession":"0001127602-21-027342","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-21-027342","line_url":"/filing/0001127602-21-027342#line-5","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105000.0,"shares_display":"105,000","price_per_share":15.4,"price_display":"15.40","price_state":"stated","total_value":1617000.0,"total_display":"1,617,000.00","total_whole":"1,617,000","shares_owned_after":65073.0,"shares_owned_after_display":"65,073","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-15","filed_date":"2021-10-19","scope":"insider"},{"id":9237930,"accession":"0001169245-22-000067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001169245-22-000067","line_url":"/filing/0001169245-22-000067#line-1","is_derivative":false,"issuer_cik":"0001169245","issuer_name":"PhaseBio Pharmaceuticals Inc","issuer_ticker":"PHAS","issuer_name_source":null,"issuer_url":"/issuer/0001169245","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":3.08,"price_display":"3.08","price_state":"stated","total_value":9240.0,"total_display":"9,240.00","total_whole":"9,240","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-18","filed_date":"2022-05-20","scope":"insider"},{"id":4963679,"accession":"0001169245-21-000083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001169245-21-000083","line_url":"/filing/0001169245-21-000083#line-1","is_derivative":false,"issuer_cik":"0001169245","issuer_name":"PhaseBio Pharmaceuticals Inc","issuer_ticker":"PHAS","issuer_name_source":null,"issuer_url":"/issuer/0001169245","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":3.08,"price_display":"3.08","price_state":"stated","total_value":9240.0,"total_display":"9,240.00","total_whole":"9,240","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-18","filed_date":"2021-08-19","scope":"insider"},{"id":4229641,"accession":"0001209191-21-051883","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-051883","line_url":"/filing/0001209191-21-051883#line-1","is_derivative":false,"issuer_cik":"0001379222","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001379222","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":5.68,"price_display":"5.68","price_state":"stated","total_value":17040.0,"total_display":"17,040.00","total_whole":"17,040","shares_owned_after":13000.0,"shares_owned_after_display":"13,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-17","scope":"insider"},{"id":4170922,"accession":"0001127602-21-019792","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-21-019792","line_url":"/filing/0001127602-21-019792#line-3","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23333.0,"shares_display":"23,333","price_per_share":16.86,"price_display":"16.86","price_state":"stated","total_value":393394.38,"total_display":"393,394.38","total_whole":"393,394","shares_owned_after":65073.0,"shares_owned_after_display":"65,073","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-10","filed_date":"2021-06-14","scope":"insider"},{"id":5093884,"accession":"0001209191-21-020488","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-020488","line_url":"/filing/0001209191-21-020488#line-1","is_derivative":false,"issuer_cik":"0001379222","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001379222","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.105,"price_display":"3.10","price_state":"stated","total_value":15525.0,"total_display":"15,525.00","total_whole":"15,525","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-12","filed_date":"2021-03-15","scope":"insider"},{"id":3114103,"accession":"0001209191-20-031325","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-031325","line_url":"/filing/0001209191-20-031325#line-1","is_derivative":false,"issuer_cik":"0001379222","issuer_name":"Clearside Biomedical, Inc.","issuer_ticker":"CLSD","issuer_name_source":null,"issuer_url":"/issuer/0001379222","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.85,"price_display":"1.85","price_state":"stated","total_value":9250.0,"total_display":"9,250.00","total_whole":"9,250","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-20","filed_date":"2020-05-21","scope":"insider"},{"id":8286947,"accession":"0001127602-19-033022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-19-033022","line_url":"/filing/0001127602-19-033022#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":14500.0,"total_display":"14,500.00","total_whole":"14,500","shares_owned_after":53046.0,"shares_owned_after_display":"53,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-18","scope":"insider"},{"id":6338440,"accession":"0001209191-18-062934","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-062934","line_url":"/filing/0001209191-18-062934#line-1","is_derivative":false,"issuer_cik":"0001169245","issuer_name":"PhaseBio Pharmaceuticals Inc","issuer_ticker":"PHAS","issuer_name_source":null,"issuer_url":"/issuer/0001169245","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.46,"price_display":"4.46","price_state":"stated","total_value":4460.0,"total_display":"4,460.00","total_whole":"4,460","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-17","filed_date":"2018-12-17","scope":"insider"},{"id":6479663,"accession":"0001209191-18-058924","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-058924","line_url":"/filing/0001209191-18-058924#line-1","is_derivative":false,"issuer_cik":"0001379222","issuer_name":"Endo International plc","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001379222","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":12.83,"price_display":"12.83","price_state":"stated","total_value":128300.0,"total_display":"128,300.00","total_whole":"128,300","shares_owned_after":49970.0,"shares_owned_after_display":"49,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-15","filed_date":"2018-11-16","scope":"insider"},{"id":5113158,"accession":"0001209191-17-019749","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-019749","line_url":"/filing/0001209191-17-019749#line-1","is_derivative":false,"issuer_cik":"0001379222","issuer_name":"Endo International plc","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001379222","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5325.0,"shares_display":"5,325","price_per_share":10.82,"price_display":"10.82","price_state":"stated","total_value":57616.5,"total_display":"57,616.50","total_whole":"57,617","shares_owned_after":31252.0,"shares_owned_after_display":"31,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-09","filed_date":"2017-03-10","scope":"insider"},{"id":2782085,"accession":"0001209191-16-105830","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-105830","line_url":"/filing/0001209191-16-105830#line-2","is_derivative":false,"issuer_cik":"0001379222","issuer_name":"Endo International plc","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001379222","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3413.0,"shares_display":"3,413","price_per_share":42.19,"price_display":"42.19","price_state":"stated","total_value":143994.47,"total_display":"143,994.47","total_whole":"143,994","shares_owned_after":36577.0,"shares_owned_after_display":"36,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-01","filed_date":"2016-03-03","scope":"insider"},{"id":8396776,"accession":"0001127602-15-007601","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-15-007601","line_url":"/filing/0001127602-15-007601#line-1","is_derivative":false,"issuer_cik":"0000882796","issuer_name":"BIOCRYST PHARMACEUTICALS INC","issuer_ticker":"BCRX","issuer_name_source":null,"issuer_url":"/issuer/0000882796","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":10.27,"price_display":"10.27","price_state":"stated","total_value":102700.0,"total_display":"102,700.00","total_whole":"102,700","shares_owned_after":15891.0,"shares_owned_after_display":"15,891","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-20","filed_date":"2015-02-23","scope":"insider"},{"id":6397987,"accession":"0001127602-14-025794","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-14-025794","line_url":"/filing/0001127602-14-025794#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":65.0,"price_display":"65.00","price_state":"stated","total_value":585000.0,"total_display":"585,000.00","total_whole":"585,000","shares_owned_after":5951.0,"shares_owned_after_display":"5,951","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-18","filed_date":"2014-08-18","scope":"insider"},{"id":6789138,"accession":"0001209191-14-019574","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-019574","line_url":"/filing/0001209191-14-019574#line-2","is_derivative":false,"issuer_cik":"0001379222","issuer_name":"Endo International plc","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001379222","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":72.12,"price_display":"72.12","price_state":"stated","total_value":360600.0,"total_display":"360,600.00","total_whole":"360,600","shares_owned_after":20483.0,"shares_owned_after_display":"20,483","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-10","filed_date":"2014-03-11","scope":"insider"},{"id":5320520,"accession":"0001127602-13-023584","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-13-023584","line_url":"/filing/0001127602-13-023584#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":53.87,"price_display":"53.87","price_state":"stated","total_value":269350.0,"total_display":"269,350.00","total_whole":"269,350","shares_owned_after":4847.0,"shares_owned_after_display":"4,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-26","filed_date":"2013-07-29","scope":"insider"},{"id":5151819,"accession":"0001127602-13-014568","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-13-014568","line_url":"/filing/0001127602-13-014568#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":46.2261,"price_display":"46.23","price_state":"stated","total_value":231130.5,"total_display":"231,130.50","total_whole":"231,131","shares_owned_after":3500.0,"shares_owned_after_display":"3,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-26","filed_date":"2013-04-26","scope":"insider"},{"id":4961036,"accession":"0001127602-13-003199","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-13-003199","line_url":"/filing/0001127602-13-003199#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":43.268,"price_display":"43.27","price_state":"stated","total_value":216340.0,"total_display":"216,340.00","total_whole":"216,340","shares_owned_after":3500.0,"shares_owned_after_display":"3,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-28","filed_date":"2013-01-30","scope":"insider"},{"id":2194318,"accession":"0001127602-12-029212","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-12-029212","line_url":"/filing/0001127602-12-029212#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":43.523,"price_display":"43.52","price_state":"stated","total_value":217615.0,"total_display":"217,615.00","total_whole":"217,615","shares_owned_after":3500.0,"shares_owned_after_display":"3,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-26","filed_date":"2012-10-30","scope":"insider"},{"id":8956694,"accession":"0001127602-11-027825","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-11-027825","line_url":"/filing/0001127602-11-027825","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":38.6564,"price_display":"38.66","price_state":"stated","total_value":57984.6,"total_display":"57,984.60","total_whole":"57,985","shares_owned_after":3500.0,"shares_owned_after_display":"3,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-26","filed_date":"2011-10-28","scope":"insider","n_lines":2},{"id":7261192,"accession":"0001209191-10-059443","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-059443","line_url":"/filing/0001209191-10-059443#line-1","is_derivative":false,"issuer_cik":"0001100962","issuer_name":"ENDO PHARMACEUTICALS HOLDINGS INC","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001100962","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value, $.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":36.38,"price_display":"36.38","price_state":"stated","total_value":36380.0,"total_display":"36,380.00","total_whole":"36,380","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-07","filed_date":"2010-12-09","scope":"insider"},{"id":7366746,"accession":"0001181431-10-055080","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-055080","line_url":"/filing/0001181431-10-055080","is_derivative":false,"issuer_cik":"0001040416","issuer_name":"INSPIRE PHARMACEUTICALS INC","issuer_ticker":"ISPH","issuer_name_source":null,"issuer_url":"/issuer/0001040416","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":6.9877142857142855,"price_display":"6.99","price_state":"stated","total_value":48914.0,"total_display":"48,914.00","total_whole":"48,914","shares_owned_after":14800.0,"shares_owned_after_display":"14,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-09","filed_date":"2010-11-12","scope":"insider","n_lines":2},{"id":5985737,"accession":"0001209191-09-027057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-027057","line_url":"/filing/0001209191-09-027057#line-1","is_derivative":false,"issuer_cik":"0001100962","issuer_name":"ENDO PHARMACEUTICALS HOLDINGS INC","issuer_ticker":"ENDP","issuer_name_source":null,"issuer_url":"/issuer/0001100962","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $.01 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":16.31,"price_display":"16.31","price_state":"stated","total_value":48930.0,"total_display":"48,930.00","total_whole":"48,930","shares_owned_after":6908.0,"shares_owned_after_display":"6,908","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-13","filed_date":"2009-05-18","scope":"insider"},{"id":3662088,"accession":"0001210238-08-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001210238-08-000005","line_url":"/filing/0001210238-08-000005","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":21.03476,"price_display":"21.03","price_state":"stated","total_value":42069.52,"total_display":"42,069.52","total_whole":"42,070","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-10-23","filed_date":"2008-10-27","scope":"insider","n_lines":2},{"id":6965398,"accession":"0001181431-07-018868","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-07-018868","line_url":"/filing/0001181431-07-018868#line-1","is_derivative":false,"issuer_cik":"0001040416","issuer_name":"INSPIRE PHARMACEUTICALS INC","issuer_ticker":"ISPH","issuer_name_source":null,"issuer_url":"/issuer/0001040416","owner_cik":"0001379222","owner_name":"Hutson Nancy J","owner_display_name":"Hutson Nancy J","owner_url":"/insider/0001379222","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7800.0,"shares_display":"7,800","price_per_share":6.3499,"price_display":"6.35","price_state":"stated","total_value":49529.22,"total_display":"49,529.22","total_whole":"49,529","shares_owned_after":7800.0,"shares_owned_after_display":"7,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-03-12","filed_date":"2007-03-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":33,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":20,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":33},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000882796","name":"BIOCRYST PHARMACEUTICALS INC","url":"/issuer/0000882796","role":"Director","n_filings":7,"first_seen":"2015-02-23","last_seen":"2024-12-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001539029","name":"Clearside Biomedical, Inc.","url":"/issuer/0001539029","role":"Director","n_filings":5,"first_seen":"2020-05-21","last_seen":"2023-10-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001169245","name":"PhaseBio Pharmaceuticals Inc","url":"/issuer/0001169245","role":"Director","n_filings":3,"first_seen":"2018-12-17","last_seen":"2022-05-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001593034","name":"Endo International plc","url":"/issuer/0001593034","role":"Director","n_filings":4,"first_seen":"2014-03-11","last_seen":"2018-11-16"},{"type":"issuer","type_label":"ISSUER","cik":"0000912183","name":"CUBIST PHARMACEUTICALS INC","url":"/issuer/0000912183","role":"Director","n_filings":7,"first_seen":"2008-10-27","last_seen":"2014-08-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001100962","name":"ENDO PHARMACEUTICALS HOLDINGS INC","url":"/issuer/0001100962","role":"Director","n_filings":2,"first_seen":"2009-05-18","last_seen":"2010-12-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001040416","name":"INSPIRE PHARMACEUTICALS INC","url":"/issuer/0001040416","role":"Director","n_filings":2,"first_seen":"2007-03-13","last_seen":"2010-11-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001379222","retrieved_at":"2026-08-25T21:03:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}